CELIXIR LIMITED

Active Stratford-Upon-Avon

Research and experimental development on biotechnology

0 employees website.com
Research and experimental development on biotechnology
C

CELIXIR LIMITED

Research and experimental development on biotechnology

Founded 22 Apr 2016 Active Stratford-Upon-Avon, England 0 employees website.com
Research and experimental development on biotechnology

Previous Company Names

CARDIOGENI LIMITED 2 Oct 2024 — 6 Jan 2025
CELIXIR INNOVATIONS LIMITED 28 Dec 2016 — 2 Oct 2024
CELIXIR LIMITED 22 Apr 2016 — 28 Dec 2016
Accounts Submitted 12 Feb 2026 Next due 31 Jan 2027 7 months remaining
Confirmation Submitted 26 Mar 2026 Next due 8 Apr 2027 10 months remaining
Net assets £1 £0 2025 year on year
Total assets £1 £0 2025 year on year
Total Liabilities £0
Charges None No charges registered

Contact & Details

Contact

Registered Address

Celixir House Stratford-Upon-Avon Business & Technology Park Innovation Way Stratford-Upon-Avon CV37 7GZ England

Full company profile for CELIXIR LIMITED (10141208), an active company based in Stratford-Upon-Avon, England. Incorporated 22 Apr 2016. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 May → 30 Apr 2025
Type micro-entity
Next accounts 30 Apr 2026
Due by 31 Jan 2027 7 months remaining

Net Assets, Total Assets & Total Liabilities (2017–2025)

Cash in Bank

N/A

Net Assets

£1.00

Total Liabilities

N/A

Turnover

N/A

Employees

N/A

Debt Ratio

N/A

Financial History

Revenue, profit, EBITDA and key financial figures

2025
30 Apr Year End
2024
30 Apr Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

2 active 1 resigned
Status
Cardiogeni PlcCorporate-directorUnknownUnknown15 Jan 2019Active
Reginald, Ajan TrevorDirectorBritishUnited Kingdom5422 Apr 2016Active

Shareholders

Shareholders (1)

Cardiogeni Plc
100.0%

Persons with Significant Control

Persons with Significant Control (1)

1 Active 2 Ceased

Cardiogeni Plc

United Kingdom

Active
Notified 6 Jan 2025
Nature of Control
  • Significant Influence Or Control,significant Influence Or Control As Firm

Cell Therapy Limited

Ceased 20 Apr 2018

Ceased

Celixir Plc

Ceased 6 Jan 2025

Ceased

Group Structure

Group Structure

CARDIOGENI PLC united kingdom
CELIXIR LIMITED Current Company
INNATELY LIMITED united kingdom

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
26 Mar 2026Confirmation StatementConfirmation statement made on 25 Mar 2026 with no updates
12 Feb 2026AccountsAnnual accounts made up to 30 Apr 2025
23 May 2025Confirmation StatementConfirmation statement made on 21 Apr 2025 with updates
24 Feb 2025AccountsAnnual accounts made up to 30 Apr 2024
15 Jan 2025OfficersChange Corporate Director Company With Change Date
26 Mar 2026 Confirmation Statement

Confirmation statement made on 25 Mar 2026 with no updates

12 Feb 2026 Accounts

Annual accounts made up to 30 Apr 2025

23 May 2025 Confirmation Statement

Confirmation statement made on 21 Apr 2025 with updates

24 Feb 2025 Accounts

Annual accounts made up to 30 Apr 2024

15 Jan 2025 Officers

Change Corporate Director Company With Change Date

Recent Activity

Latest Activity

Confirmation statement made on 25 Mar 2026 with no updates

2 months ago on 26 Mar 2026

Annual accounts made up to 30 Apr 2025

3 months ago on 12 Feb 2026

Confirmation statement made on 21 Apr 2025 with updates

1 years ago on 23 May 2025

Annual accounts made up to 30 Apr 2024

1 years ago on 24 Feb 2025

Change Corporate Director Company With Change Date

1 years ago on 15 Jan 2025